logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Biagio Ricciuti

Harvard Medical School
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study

免疫疗法在伴有心包积液的晚期NSCLC中的有效性和安全性：一项全球回顾性多中心研究

Oncologist
IF4.2
2026-07-250
OAAI
Talal El Zarif, MD; Sarah Abou Alaiwi, MD; Amin H Nassar, MD; Eleonora Gariazzo, MD; Valentina Santo, MD; Edoardo Garbo, MD; Mihaela Aldea, MD, PhD; Francesco Paoloni, MD; Sagal Pannu, MD; Karl Semaan, MD, MSc; Omar Chehab, MD, MSc; Malak Hoballah, MD; Vishal Navani, MBBS, MA; Yizhuo Gao, MD; Daniel Meyers, MD, MSc; Igor Stukalin, MD; Arjun Mittra, MD; Mingjia Li, MD; Nicholas Jones, MD; Shirly Grynberg, MD; Ronnie Shapira, MD; Alexi Vasbinder, PhD; Salim S Hayek, MD; Elias Bou Farhat, MD; Marc Eid, MD, MSc; Eddy Saad, MD, MSc; Dory Freeman, MSN, APRN; Kaushal Parikh, MD; Aakash Desai, MD, MPH; Caleb Smith, MD; Edward El-Am, MD; Frank Aboubakar Nana, MD; Simone Foderaro, MD; Javier Baena, MD; Mercedes Herrera, MD; Alessio Cortellini, MD, PhD; David J Pinato, MD, PhD; James Korolewicz, MD; Chul Kim, MD, MPH; Paul Sackstein, MD; Ryan A Denu, MD, PhD; Walid Macaron, MD; Noha Abdel-Wahab, MD, PhD; Tomas G Neilan, MD, MPH; João A C Lima, MD, MBA; Narjust Florez, MD; Pasi Janne, MD, PhD; Biagio Ricciuti, MD, PhD; Federica Pecci, MD; Toni K Choueiri, MD; Jennifer M Kwan, MD, PhD; Abdul Rafeh Naqash, MD; null
Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation

宿主相关因素对非小细胞肺癌免疫治疗反应的影响：体成分、代谢、性别和免疫调节的相互作用

Current Oncology Reports
IF5
2025-12-230
OAAI
Valentina Santo; Leonardo Brunetti; Federica Pecci; Marianna Peroni; Giulia Barnini; Francesco Paoloni; Sebastiano Buti; Marcello Tiseo; Biagio Ricciuti; David James Pinato; Alessio Cortellini
CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success

CRATER肿瘤微环境促进CD8+ T细胞浸润，并与免疫治疗效果相关

Cell
IF42.5
2025-10-170
OAAI
Aya Ludin; Georgia L. Stirtz; Asaf Tal; Ajit J. Nirmal; Kathleen L. Pfaff; Michael Manos; Naomi Besson; Nebiyat Eskndir; Billie Porter; Stephanie M. Jones; Hannah M. Faulkner; Qiyu Gong; Sophia Liu; Irving Barrera; Lijian Wu; Cecilia Pessoa Rodrigues; Aditi Sahu; Elizabeth Jerison; Joao V. Alessi; Biagio Ricciuti; Douglas S. Richardson; Jodi D. Weiss; Hadley M. Moreau; Meredith E. Stanhope; Alexander B. Afeyan; James Sefton; Wyatt D. McCall; Emily Formato; Song Yang; Yi Zhou; David P. Hoytema van Konijnenburg; Hannah L. Cole; Miguel Cordova; Liang Deng; Milind Rajadhyaksha; Stephen R. Quake; Mark M. Awad; Fei Chen; Kai W. Wucherpfennig; Peter K. Sorger; F. Stephen Hodi; Scott J. Rodig; George F. Murphy; Leonard I. Zon
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中，具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局：基于Transformer的AI用于表征预后复杂性

Lung Cancer
IF4.4
2025-10-160
OAAI
Alessio Cortellini; Edoardo Garbo; Giulia La Cava; Fabrizio Citarella; Valentina Santo; Leonardo Brunetti; David J Pinato; Jarushka Naidoo; Monica Loza; Carlo Genova; Scott Gettinger; So Yeon Kim; Ritujith Jayakrishnan; Talal El Zarif; Marco Russano; Federica Pecci; Alessandro Di Federico; Michele Montrone; Dwight H Owen; Diego Signorelli; Mingjia Li; Andrea Camerini; Balazs Halmos; Bruno Vincenzi; Giulio Metro; Sai Yendamuri; Francesco Grossi; Eleni Josephides; Bartłomiej Tomasik; Raffaele Giusti; Emilio Bria; Martin Sebastian; Maximilian Rost; Fabian Acker; Lorenza Landi; Francesca Mazzoni; Alessandro Morabito; Alessandro Leonetti; Luca Cantini; Giannis Mountzios; Sukumar Kalvapudi; David O’Reilly; Eleni Karapanagiotou; Isabelle Monnet; Javier Baena; Marianna Macerelli; Margarita Majem; Aida Piedra; Diego L Cortinovis; Giuseppe Tonini; Gabriele Minuti; Laura Mezquita; Teresa Gorria; Teresa Beninato; Giuseppe Lo Russo; Arsela PrelaJ; Andrea De Giglio; Federica Biello; Frank Aboubakar Nana; Anne-Marie C. Dingemans; Joachim GJV Aerts; Roberto Ferrara; Taher Abu Hejleh; Kazuki Takada; Abdul R Naqash; Marina C Garassino; Heather A. Wakelee; Amin Nassar; Biagio Ricciuti; Paolo Soda; Camillo Maria Caruso; Valerio Guarrasi
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

晚期非小细胞肺癌患者接受双重CTLA-4和PD-L1或PD-1阻断治疗及生物标志物基础亚组分析的长期总生存：一项系统评价和重建个体患者数据荟萃分析

The Lancet Oncology
IF0
2025-09-290
PRE
Alessandro Di Federico; Sara Stumpo; Francesco Mantuano; Andrea De Giglio; Francesca Lo Bianco; Federica Pecci; Joao V Alessi; Xinan Wang; Francesca Sperandi; Barbara Melotti; Francesco Gelsomino; Ferdinandos Skoulidis; Marina C Garassino; Solange Peters; Mark M Awad; Andrea Ardizzoni; Biagio Ricciuti
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study

一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较（FRONT-BRAF）：一项多中心、回顾性队列研究

The Lancet Oncology
IF0
2025-09-290
PRE
Alessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers with Different MET Exon 14 Skipping Mutations.

简报：DNA测序在区分具有不同MET外显子14跳跃突变的不同原发性肺癌中的关键作用。

Journal of Thoracic Oncology
IF20.8
2025-09-200
PRE
Federica Pecci; Prashasti Agrawal; Jessica S. Ross; Biagio Ricciuti; Seshiru Nakazawa; Alessandro Di Federico; Mihaela Aldea; Edoardo Garbo; Valentina Santo; Eleonora Gariazzo; Maisam Makarem; Danielle Haradon; Igor Odintsov; Marina Baine; William Travis; Soo-Ryum Yang; Paula A.Ugalde Figueroa; Katherine D. Gray; Mizuki Nishino; Maria Mayoral Penalva; Pasi A. Jänne; Lynette M. Sholl; Mark M. Awad; Jamie E. Chaft
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival

非小细胞肺癌患者新辅助化免疫治疗的实际结果：手术、病理完全缓解和事件无进展生存的预测因素

Cancer
IF5.1
2025-09-090
PRE
Alissa J. Cooper MD; Edoardo Garbo MD; Andrea Arfe PhD; Michael Conroy MB, BCh, Bao; Narek Shaverdian MD; Matthew Bott MD; Teresa Gorria MD; Federica Pecci MD; Mihaela Aldea MD, PhD; Valsamo Anagnostou MD, PhD; Adam Schoenfeld MD; Daniel Gomez MD, MBA; Patrick M. Forde MBBCh; Mark M. Awad MD, PhD; David R. Jones MD; Biagio Ricciuti MD, PhD; Jamie E. Chaft MD
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis

铂类化疗和CTLA-4抑制对非小细胞肺癌中一线抗PD-1/PD-L1药物获得性耐药的影响：一项系统综述和重构的个体患者数据分析

eClinicalMedicine
IF10
2025-09-020
PREAI
Sara Oresti; Fabio Salomone; Antonio Nuccio; Francesca Rita Ogliari; Silvia Teresa Riva; Ludovica Mollica; Alessandra Bulotta; Maria Grazia Viganò; Francesco Maria Venanzi; Francesco Passaretti; Ludovica Papotto; Anna Di Lello; Michele Ferrara; Giorgia Foggetti; Giuseppe Damiano; Alberto Servetto; Raffaele Califano; Massimo Di Maio; Biagio Ricciuti; Alessio Cortellini; Martin Reck; Michela Cinquini; Valter Torri; Giuseppe Viscardi; Roberto Ferrara
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multi-Center Retrospective Study

肺肉瘤样癌的特定临床基因组学特征及与免疫治疗的相关性：一项多中心回顾性研究

Journal of Thoracic Oncology
IF20.8
2025-07-250
OAAI
Lingzhi Hong; Alessandro Di Federico; Bolun Liu; Alissa J. Cooper; Joao V. Alessi; Phoebe Clark; Waree Rinsurongkawong; Chingyi Young; Hui Li; Kang Qin; Muhammad Aminu; Valentina Santo; Yasir Elamin; Boris Sepesi; Jeff Lewis; Don L. Gibbons; Ara A. Vaporciyan; J. Jack Lee; Xiuning Le; Jia Wu; Sinchita Roy-Chowdhuri; Mark J. Routbort; P. Andrew Futreal; John V. Heymach; Mark M. Awad; Adam J. Schoenfeld; Jianjun Zhang; Biagio Ricciuti; Lei Deng; Natalie I. Vokes
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

机器学习驱动的转移性非小细胞肺癌免疫治疗适应性策略

Nature Communications
IF15.7
2025-07-240
OAAI
Maliazurina B. Saad; Qasem Al-Tashi; Lingzhi Hong; Vivek Verma; Wentao Li; Daniel Boiarsky; Shenduo Li; Milena Petranovic; Carol C. Wu; Brett W. Carter; Girish S. Shroff; Tina Cascone; Xiuning Le; Yasir Y. Elamin; Mehmet Altan; Simon Heeke; Ajay Sheshadri; Joe Y. Chang; Percy P. Lee; Zhongxing Liao; Don L. Gibbons; Ara A. Vaporciyan; J. Jack Lee; Ignacio I. Wistuba; Cara Haymaker; Seyedali Mirjalili; David Jaffray; Justin F. Gainor; Yanyan Lou; Alessandro Di Federico; Federica Pecci; Mark Awad; Biagio Ricciuti; John V. Heymach; Natalie I. Vokes; Jianjun Zhang; Jia Wu
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small cell lung cancer

DNA甲基转移酶3A（DNMT3A）突变与非小细胞肺癌中PD-(L)1阻断疗法的疗效

Annals of Oncology
IF65.4
2025-06-180
PRE
B. Ricciuti; S. Scalera; X. Wang; A. Elkrief; M. Tagliamento; E. Gariazzo; F. Paoloni; P.G. Miller; F. Pecci; A. Di Federico; V. Santo; J.V. Alessi; M. Aldea; E. Garbo; G. Lamberti; W. Zrafi; J.B. Micol; L.M. Sholl; M. Nishino; F. Cappuzzo; N. Calonaci; G. Caravagna; R. Ferrara; B. Besse; A. Schoenfeld; M. Maugeri-Sacca; M.M. Awad
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer

新辅助PD-1和PD-L1阻断联合化疗治疗 borderline resectable 和 unresectable Stage III 非小细胞肺癌

JAMA ONCOLOGY
IF20.1
2025-05-220
PRE
Ricciuti, Biagio; Fusco, Francesca; Cooper, Alissa; Pecci, Federica; Aldea, Mihaela; Wang, Xinan; Mayoral Penalva, Maria; Ginsberg, Michelle; Sholl, Lynette M.; Nishino, Mizuki; Di Federico, Alessandro; Shaverdian, Narek; Bott, Matthew; Santo, Valentina; Rendina, Erino; Trisolini, Rocco; Ramella, Sara; Gallina, Filippo; Melis, Enrico; Buglioni, Simonetta; Minuti, Gabriele; Landi, Lorenza; Ugalde Figueroa, Paula A.; Shaw, Alice T.; Chaft, Jamie; Awad, Mark M.; Cappuzzo, Federico
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC

MET激酶域激活突变与其他驱动癌基因共发生，并介导非小细胞肺癌对靶向治疗的耐药性

Journal of Thoracic Oncology
IF20.8
2025-04-020
PRE
Seshiru Nakazawa; Federica Pecci; Biagio Ricciuti; Felix H. Gottlieb; Francesco Facchinetti; Guilherme Harada; Monica F. Chen; Matteo Repetto; Flavia Giacomini; Jie Jiang; Marie-Anaïs Locquet; Maisam Makarem; Joao V. Alessi; Alessandro Di Federico; Mihaela Aldea; Edoardo Garbo; Malini M. Gandhi; Arushi Saini; Danielle Haradon; Magda Bahcall; William W. Feng; Jessica K. Lee; Alexa B. Schrock; Alexander Drilon; Mark M. Awad; Pasi A. Jänne
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

黏液性组织学特征的肺腺癌：临床、基因组学和免疫微环境特征及对基于免疫疗法治疗和KRASG12C抑制剂的疗效

ANNALS OF ONCOLOGY
IF65.4
2025-03-014
PRE
Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; Makarem, M.; Gandhi, M. M.; Garbo, E.; Saini, A.; De Giglio, A.; Favorito, V.; Scalera, S.; Cipriani, L.; Marinelli, D.; Haradon, D.; Nguyen, T.; Haradon, J.; Voligny, E.; Vaz, V.; Gelsomino, F.; Sperandi, F.; Melotti, B.; Ladanyi, M.; Zhang, J.; Gibbons, D. L.; Heymach, J. V.; Nishino, M.; Lindsay, J.; Rodig, S. J.; Pfaff, K.; Sholl, L. M.; Wang, X.; Johnson, B. E.; Janne, P. A.; Rekhtman, N.; Maugeri-Sacca, M.; Heist, R. S.; Ardizzoni, A.; Awad, M. M.; Arbour, K. C.; Schoenfeld, A. J.; Vokes, N. I.; Luo, J.
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients

老年非小细胞肺癌患者（≥80岁）的肿瘤免疫表型相关性及PD-L1高表达（≥50%）患者接受一线帕博利珠单抗治疗的结局

Clinical Lung Cancer
IF3.3
2025-02-040
PRE
Adriana P.C. Barrichello; Arielle Elkrief; Biagio Ricciuti; Teja Ganta; Thomas U. Marron; Xinan Wang; William Lotter; James Lindsay; Valentina Santo; Alessio Cortellini; Bijaya Sharma; Kristen Felt; Kathleen Pfaff; Giuseppe Lamberti; Federica Pecci; Alessandro Di Federico; Maisam Makarem; Malini M. Gandhi; Tom Nguyen; Danielle Haradon; Victor R. Vaz; Bruce E. Johnson; Neha Debnath; Yinghong Wang; Andrew G. Kuang; Anwaar Saeed; Maluki Radford; Christine M. Lovly; Caroline A. Nebhan; David J. Pinato; Scott J. Rodig; Adam J. Schoenfeld; Mark M. Awad; Joao V. Alessi; Abdul Rafeh Naqash
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLC

STK11、KEAP1和SMARCA4基因拷贝数缺失：临床病理特征及其与免疫治疗联合或单独化疗在非鳞状NSCLC中疗效的关联

Journal of Thoracic Oncology
IF20.8
2025-01-270
PRE
Malini M. Gandhi; Arielle Elkrief; Catherine Gutierrez Moore; Biagio Ricciuti; Joao V. Alessi; Allison L. Richards; Sam Tischfield; Jessica Williams; Giuseppe Lamberti; Federica Pecci; Alessandro Di Federico; Maisam Makarem; Bruce E. Johnson; Mizuki Nishino; Lynette M. Sholl; Adam J. Schoenfeld; Mark M. Awad

研究方向

暂未获取到该数据
M
Mark M. Awad
H 指数:86论文数:1,447被引数:3.0万
J
Joao V. Alessi
H 指数:28论文数:796被引数:3,005
G
Giuseppe Lamberti
H 指数:36论文数:824被引数:4,808
A
Alessandro Di Federico
H 指数:30论文数:753被引数:3,006
F
Federica Pecci
H 指数:20论文数:628被引数:1,440
X
Xinan Wang
H 指数:24论文数:629被引数:2,492
L
Lynette M. Sholl
H 指数:97论文数:1,164被引数:3.8万
R
Rita Chiari
H 指数:52论文数:500被引数:1.1万
A
Alessio Cortellini
H 指数:51论文数:650被引数:9,045
M
Mizuki Nishino
H 指数:81论文数:822被引数:2.4万